• 1
    Schuster SJ, Koury ST, Bohler M, Salceda S, Caro J. Cellular sites of extrarenal and renal erythropoietin production in anaemic rats. Br J Haematol 1992;81: 1539.
  • 2
    Silva M, Grillot D, Benito A, Richard C, Nunez G, Fernandez-Luna JL. Erythropoietin can promote erythroid progenitor survival by repressing apoptosis through Bcl-XL and Bcl-2. Blood 1996;88: 157682.
  • 3
    Tilbrook PA, Klinken SP. Erythropoietin and erythropoietin receptor. Growth Factors 1999;17: 2535.
  • 4
    Moritz KM, Lim GB, Wintour EM. Developmental regulation of erythropoietin and erythropoiesis. Am J Physiol 1997;273R: 182981.
  • 5
    Lacombe C, Mateux P. Biology of erythropoietin. Haematologica 1998;83: 72432.
  • 6
    Ebert BL, Bunn HF. Regulation of the erythropoietin gene. Blood 1999;94: 1964877.
  • 7
    Wojchowski DM, Gregory RC, Miller CP, Pandit AK, Pircher TJ. Signal transduction in the erythropoietin receptor system. Exp Cell Res 1999;253: 14356.
  • 8
    Wu H, Liu X, Jaenisch R, Lodish HF. Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor. Cell 1995;83: 5967.
  • 9
    Lin CS, Lim SK, D’Agati V, Costantini F. Differential effects of an erythropoietin receptor gene disruption on primitive and definitive erythropoiesis. Genes Dev 1996;10: 15464.
  • 10
    Vogt C, Pentz S, Rich IN. A role for the macrophage in normal erythropoiesis. III. In vitro and in vivo erythropoietin gene expression in macrophages detected by in situ hybridization. Exp Hematol 1989;17: 3917.
  • 11
    Buemi M Cavallaro E, Floccari F, Sturiale A, Aloisi C, Trimarchi M et al. The pleiotropic effects of erythropoietin in the central nervous system. J Neuropathol Exp Neurol 2003;62: 22836.
  • 12
    Conrad KP, Benyo DF, Westerhausen-Larsen A, Miles TM. Expression of erythropoietin by the human placenta. FASEB J 1996;10: 7608.
  • 13
    Kling PJ, Sullivan TM, Roberts RA, Phillips AF, Koldovsky O. Human milk as a potential enteral source of erythropietin. Pediatr Res 1998;43: 21621.
  • 14
    Anagnostou A, Liu Z, Steiner M, Chin K, Lee ES, Kessimian N et al. Erythropoietin receptor mRNA expression in human endothelial cells. Proc Natl Acad Sci USA 1994;91: 39748.
  • 15
    Juul SE, Anderson DK, Li Y, Christensen RD. Erythropoietin and erythropoietin receptor in the developing human central nervous system. Pediatr Res 1998;43: 409.
  • 16
    Fairchil D, Benyo D, Conrad KP. Expression of the erythropoietin receptor by throphoblast cells in the human placenta. Biol Reprod 1999;60: 86170.
  • 17
    Bikfalvi A, Han ZC. Angiogenic factors are hematopoietic growth factors and viceversa. Leukemia 1994;8: 5239.
  • 18
    Pelletier L, Regnard J, Fellmann A, Chabord P. An in vitro model for the study of human bone marrow angiogenesis: role of hematopoietic cytokine. Lab Invest 2000;80: 50111.
  • 19
    Ribatti D, Vacca A, Roncali L, Dammacco F. Hematopoiesis and angiogenesis: a link between two apparently independent processes. J Hematother Stem Cell Res 2000;9: 139.
  • 20
    Bussolino F, Wang JM, De Filippi P, Turrini F, Sanavio F, Edgell CJS et al. Granulocyte and granulocyte-macrophage colony stimulating factor induce human endothelial cells to migrate and proliferate. Nature 1989;337: 4713.
  • 21
    Valdembri D, Serini A, Vacca A, Ribatti D, Bussolino F. In vivo activation of JAK2/STAT-3 pathway during angiogenesis induced by GM-CSF. FASEB J 2002;16: 2257.
  • 22
    Chen H, Treeweeke AT, West DC, Till KJ, Cawley JC Zuzel, M et al. In vitro and in vivo production of vascular endothelial growth factor in chronic lymphocytic leukemia cells. Blood 2000;96: 31817.
  • 23
    Moroni E, Dell’Era P, Rusnati M, Presta M. Fibroblast growth factors and their receptors in hematopoiesis and hematological tumors. J Hematother Stem Cell Res 2002;11: 1932.
  • 24
    Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other diseases. Nat Med 1995;1: 2731.
  • 25
    Risau W. Mechanisms of angiogenesis. Nature 1997;386: 6714.
  • 26
    Raine AEG. Hypertension, blood viscosity and cardiovascular morbidity in renal failure: implications of erythropoietin therapy. Lancet 1988;1: 97.
  • 27
    Ikegaya N, Yamamoto T, Takeshita A, Watanabe T, Yonemura K, Miyajit T et al. Elevated erythropoietin receptor and transforming growth factor-1 expression in stenotic arteriovenous fistuale used for hemodialysis. J Am Soc Nephrol 2000;11: 92835.
  • 28
    Grandaliano G, Teutonico A, Allegretti A, Losappio R, Mancini A, Gesualdo L et al. The role of hyperparathyroidism, erythropoietin therapy, and CVM infection in the failure of arteriovenous fistula in hemodialysis. Kidney Int 2003;64: 7159.
  • 29
    Ribatti D, Presta M, Vacca A, Ria R, Giuliani R, Dell’Era P et al. Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. Blood 1999;93: 262736.
  • 30
    Witthuhn BA, Quelle FW, Silvennoinen O, Yi T, Tang B, Miura O et al. JAK-2 associates with erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin. Cell 1993;74: 22733.
  • 31
    Tsukada T, Eguchi K, Migita K, Kawabe Y, Nagataki S. Signal transduction of granulocyte macrophage stimulating factor in human endothelium-derived cell line. Tohoku J Exp Med 1997;183: 18594.
  • 32
    Soldi R, Primo L, Brizzi MF, Sanavio F, Aglietta M, Polentarutti N et al. Activation of JAK2 in human vascular endothelial cells by granulocyte-macrophage colony stimulating factor. Blood 1997;89: 863972.
  • 33
    Ogilvie M Yu X, Nicolas-Metral V, Pulido SM, Liu C, Ruegg UT et al. Erythropoietin stimulates proliferation and interferes with differentiation of myoblasts. J Biol Chem 2000;275: 3975461.
  • 34
    Yu X, Shacka JJ, Eells JB, Suarez-Quian C, Przygodkki RM, Bleslin-Cokic B et al. Erythropietin receptor signalling is required for normal brain development. Development 2002;129: 50516.
  • 35
    Anagnostou A, Lee ES, Kessimian N, Levinson R, Steiner M. Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells. Proc Natl Acad Sci USA 1990;87: 597882.
  • 36
    Yamaji R, Okada T, Moriya M, Naito M, Tsuruo T, Miyatake K et al. Brain capillary endothelial cells express two forms of erythropoietin receptor mRNA. Eur J Biochem 1996;239: 494500.
  • 37
    Ashley RA, Dubuque SH, Dvorak B, Woodward SS, Williams SK, Kling PJ. Erythropoietin stimulates vasculogenesis in neonatal rat mesenteric microvascular endothelial cells. Pediatrics Res 2002;51: 4728.
  • 38
    Carlini RG, Reyes AA, Rothstein M. Recombinant human erythropoietin stimulates angiogenesis in vitro. Kidney Int 1995;55: 54653.
  • 39
    Carlini RG, Dusso AS, Obialo CI, Alvarez UM, Rothstein M. Recombinat human erythropoietin (rHuEpo) increases endothelin-1 release by endothelial cells. Kidney Int 1993;43: 10105.
  • 40
    Vogel V, Kramer HJ, Backer A, Meyer-Lehnert H, Jelkmann W, Fandrey J. Effects of erythropoietin on endothelin-1 synthesis and cellular calcium messanger system in vascular endothelial cells. Am J Hypertens 1997;10: 28997.
  • 41
    Jaquet K, Krause K, Tawakol-Khodai M, Geidel S, Kuch KN. Erythropoietin and VEGF exhibit equal angiogenic potential. Microvasc Res 2002;64: 32633.
  • 42
    Wang XQ, Vaziri ND. Erythropoietin depresses nitric oxide synthase expression by human endothelial cells. Hypertension 1999;33: 8949.
  • 43
    Donnini S, Ziche M. Constitutive and inducible nitric oxide syntase: role in angiogenesis. Antioxid Redox Signal 2002;4: 81723.
  • 44
    Marrero MB, Venema RC, Ma H, Ling BN, Eaton DC. Erythropoietin receptor-operated Ca2+ channels: activation by phospholipase C-γ1. Kidney Int 1998;53: 125968.
  • 45
    Engerman RL, Pfaffenbach D, Davis MD. Cell turnover of capillaries. Lab Invest 1967;17: 73843.
  • 46
    Reynolds LP, Killilea SD. Readmer DA. Angiogenesis in the female reproductive system. FASEB J 1992;6: 88692.
  • 47
    Yasuda Y, Masuda S, Chikuma M, Inoue K, Nagao M, Sasaki R. Estrogen-dependent production of erythropoietin in uterus and its implication in uterine angiogenesis. J Biol Chem 1998;273: 253817.
  • 48
    Yasuda Y, Musha T, Tanaka H, Fujita Y, Fujita H, Utsumi H et al. Inhibition of erythropoietin signaling destroys xenografts of ovarian and uterine cancers in nude mice. Br J Cancer 2001;84: 84450.
  • 49
    Masuda S, Nagao M, Takahata K, Konishi Y, Gallyas F Jr, Tabira T et al. Functional erythropoietin receptor of the cells with neural characteristics: comparison with receptor properties of erythroid cells. J Biol Chem 1993;268: 1120816.
  • 50
    Siren AL, Knerlich F, Poser W, Gleiter CH, Bruck W, Ehrenreich H. Erythropoietin and erythropoietin receptor in human ischemic/hypoxic brain. Acta Neuropathol 2001;101: 2716.
  • 51
    Bernaudin M, Marti HH, Roussel S, Divoux D, Nouvelot A, Mackenzie ET et al. A potential role of erytropoietin in focal permanent cerebral ischemia in mice. J Cer Blood Flow Metab 1999;19: 64351.
  • 52
    Krupinski J, Kaluza J, Kumar P, Kumar S, Wang JM. Role of angiogenesis in patients with cerebral ischemic stroke. Stroke 1994;25: 17948.
  • 53
    Wei L, Erinjeri JP, Rovainen CM, Woolsey TA. Collateral growth and angiogenesis around cortical stroke. Stroke 2001;32: 217984.
  • 54
    Sakanaka M, Wen TC, Matsuda S, Masuda S, Morishita E, Nagao N et al. In vivo evidence that erythropoietin protects neurons from ischemic damage. Proc Natl Acad Sci USA 1998;95: 463540.
  • 55
    Brines ML, Ghrezzi P, Keenan S, Agnello D, De Lanerolle NC, Cerami C et al. Erythropoietin crosses the blood–brain barrier to protect against experimental brain injury. Proc Natl Acad Sci USA 2000;97: 1052631.
  • 56
    Morita M, Ohneda O, Yamashita T, Takahashi S, Suzuki N, Nakajima O et al. HLF/HIF-2α is a key factor in retinopathy of prematurity in association with erythropoietin. EMBO J 2003;22: 113446.
  • 57
    Jelkmann W. Erythropoietin: structure, control of production, and function. Physiol Rev 1992;72: 44989.
  • 58
    Chikuma M, Masuda S, Kobayashi T, Nagao M, Sasaki R. Tissue-specific regulation of erythropoietin production in the murine kidney, brain, and uterus. Am J Physiol 2000;279: E12428.
  • 59
    Masuda S, Okano K, Yamagishi M, Nagao M, Ueda M, Sasaki R. A novel site of erythropoietin production. Oxygen-dependent production in cultured rat astrocytes. J Biol Chem 1994;269: 1948893.
  • 60
    Chin K, Yu X, Beleslin-Cokic B, Liu C, Shen K, Mohrenweiser HW, Noguchi CM. Production and processing of erythropoietin receptor transcripts in brain. Mol Brain Res 2000;81: 2942.
  • 61
    Semenza GL. Hypoxia, clonal selection and the role of HIF-1 in tumor progression. Crit Rev Biochem Mol Biol 2000;35: 71103.
  • 62
    Westenfelder C, Baronowski RL. Erythropoietin stimulates proliferation of human renal carcinoma cells. Kidney Int 2000;58: 64757.
  • 63
    Acs G, Acs P, Beckwith SM, Pitts RL, Clements E, Wong K et al. Erythropoietin and erythropoietin receptor expression in human cancer. Cancer Res 2001;61: 35615.
  • 64
    Acs G, Zhang PJ, McGrath CM, Acs P, McBroom J, Mohyeldin A et al. Hypoxia-inducible erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression. Am J Pathol 2003;162: 1789806.
  • 65
    Briezel DM, Scully SP, Harrelson JM, Layfield LJ, Blan JM, Prosnitz LR et al. Tumor oxygenation predicts for the likelihood of distants metastases in human soft tissue sarcoma. Cancer Res;56: 9413.
  • 66
    Teicher BA. Hypoxia and drug resistance. Cancer Metastasis Rev 1994;13: 13968.
  • 67
    Olujohungbe A, Handa S, Holmes J. Does erythroppoietin accelerate malignant transformation in multiple myeloma? Postgrad Med J 1997;73: 1634.
  • 68
    Bunworasate U, Arnouk H, Minderman H, O'Loughlin KL, Sait SNJ, Barcos M et al. Erythropoietin-dependent transformation of myelodysplastic syndrome to acute monoblastic leukemia. Blood 2001;98: 34924.
  • 69
    Ribatti D. A potential role of erythropoietin in angiogenesis associated with myelodysplastic syndromes. Leukemia 2002;16: 1890.
  • 70
    Acs G, Zhang PJ, Rebbeck TR, Acs P, Verma A. Immunohistochemical expression of erythropoietin and erythropoietin receptor in breast carcinoma. Cancer 2002;95: 96981.
  • 71
    Ribatti D, Marzullo A, Nico B, Crivellato E, Ria R, Vacca A. Erytropoietin is an angiogenic factor in gastric carcinoma. Histopathology 2003;42: 24650.
  • 72
    Yasuda Y, Fujita Y, Masuda S, Musha T, Ueda K, Tanaka H et al. Erythropietin is involved in growth and angiogenesis in malignant tumours of female reproductive organs. Carcinogenesis 2002;23: 1797805.
  • 73
    Krieg M, Marti HH, Plate KH. Coexpression of erythropoietin and vascular endothelial growth factor in nervous system tumors associated with von Hippel-Lindau tumor suppressor gene loss of function. Blood 1998;92: 338893.
  • 74
    Bjornson CR, Rietze RL, Reynolds BA, Magli MC, Vescovi AL. Turning brain into blood: a hematopoietic fate adopted by adult neural stem cells in vivo. Science 1999;283: 5347.